George Golumbeski is of Sage Therapeutics, Inc.. Currently has a direct ownership of 8,000 shares of SAGE, which is worth approximately $62,640. The most recent transaction as insider was on May 05, 2022, when has been sold 8,000 shares (Common Stock) at a price of $31.45 per share, resulting in proceeds of $251,600. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8K
0% 3M change
0% 12M change
Total Value Held $62,640

George Golumbeski Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 05 2022
BUY
Open market or private purchase
$251,600 $31.45 p/Share
8,000 Added 50.0%
8,000 Common Stock

Also insider at

STTK
Shattuck Labs, Inc. Healthcare
MURA
Mural Oncology plc
GG

George Golumbeski

Cambridge, MA

Track Institutional and Insider Activities on SAGE

Follow Sage Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SAGE shares.

Notify only if

Insider Trading

Get notified when an Sage Therapeutics, Inc. insider buys or sells SAGE shares.

Notify only if

News

Receive news related to Sage Therapeutics, Inc.

Track Activities on SAGE